The global wound debridement market size was estimated to be US$ 5 billion in 2021 and is expected to grow at a CAGR of 6.1% between 2023 to 2032.
To increase the ability of the remaining tissue to heal, dead, damaged, diseased, thicker skin or callus, nonviable, and necrotic tissue are surgically removed from the wound. The prevalence of chronic wounds, including pressure ulcers, diabetic foot ulcers, infectious wounds, radiation wounds, arterial ulcers, and acute wounds like burns and trauma, is another important reason driving the growth of the wound debridement market.
Additionally, the market for wound debridement is growing due to an increase in diabetic foot ulcers among the elderly and an ageing population globally.
The market is expected to be driven by the growing prevalence of chronic illnesses such as pressure ulcers, diabetic foot ulcers, and other target wounds, the availability of reimbursement in developed nations, and changing lifestyles. Additionally, it is projected that rising rates of trauma events, burns, and other injuries due to incidents like road accidents will propel the market. In addition, the market is anticipated to benefit from the growing senior population and rising government and private sector activities to increase awareness of wound care procedures.
The expansion of the market for wound debridement products will benefit from the increase in research and development activities in the years to come. Additionally, manufacturers' increasing emphasis on using cutting-edge technology and the rise in emerging markets are the two key elements anticipated to create profitable growth prospects for the wound debridement products market throughout the study period.
The market for wound debridement products is anticipated to increase faster during the forecast period due to the rising frequency of injuries or trauma. Additionally, it is anticipated that the number of traffic accidents will fuel the market for wound debridement products throughout the projection period.
Another factor likely to accelerate the expansion of the market for wound debridement products shortly is the rising prevalence rate of diabetes. The prevalence of diabetes is rising among people of all ages, and factors contributing to this rise include obesity, a poor diet, and physical inactivity. People with diabetes are more likely to develop chronic wounds, especially foot ulcers, which has increased the demand for wound debridement therapies.
It is foreseen that the surge in the price of surgical and enzymatic debridement apparatus will stifle the evolution of the wound debridement market in the approaching years. Additionally, the potential for expansion in developing nations will soon offer more chances for the growth of the wound debridement market.
Another reason for the slow expansion of market can be the limited use of mechanical and surgical debridement as it increases the risk of bleeding and peri-procedural pain. Additionally, it is anticipated that a shortage of skilled labour and uniform usage rules will impede market expansion.
There are no established protocols or usage indications for the use of devices like hydrological debridement devices, low-frequency ultrasound, or surgical wound debridement. Additionally, insufficiently qualified experts are available to assist patients in using these devices in long-term treatment plans for various illnesses.
The market is divided into Gels, Ointments & Creams, Surgical Instruments, Medical Gauzes, Mechanical Debridement Pads, Ultrasonic Devices, and Other based on the type of product it contains. During the forecast period, the segment for ultrasonic debridement products is predicted to increase at the fastest rate. This can be mostly due to elements like their excellent debriding efficacy and debridement precision.
The Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical & Traumatic Wounds, Burns, and other segments of the market are divided based on the kind of wound. The market segment with the greatest anticipated growth rate throughout the projection period is diabetic foot ulcers. The main contributing variables are the rising incidence of diabetes and the rise in older people.
The market is divided into Autolytic Methods, Enzymatic Methods, Surgical Methods, Mechanical Methods, and Others based on the method. The global wound debridement market category with the biggest share was enzymatic debridement products. This is primarily due to things like their excellent debriding performance.
The market is divided into Hospitals, Clinics, and Other based on the end user. Hospitals held the largest market share of all industries. The elements can be linked to the infrastructure's accessibility and the presence of qualified personnel in hospitals.
North America held the greatest market share for wound debridement, and it is anticipated that it will continue to hold this position during the forecast period. This is explained by a growth in the number of sports injuries, auto accidents, and chronic wounds in the area, which has increased the need for wound debridement products for auto accidents and sports injuries. Additionally, it is predicted that the market will grow throughout the projection period due to improvements in the healthcare infrastructure.
The presence of a sizable patient population and rising knowledge of cutting-edge healthcare solutions are the main drivers of growth in the European region. Additionally, the presence of significant key players and the advancement of cutting-edge technology in this area are the key factors anticipated to accelerate the expansion of the market for wound debridement products during the projection year.
Accumulation in cases of burns and trauma, economic development, prospering healthcare infrastructure, the presence of untapped resources, and an increase in the prevalence of chronic diseases, particularly diabetes, the wound debridement market in emerging countries in Asia-Pacific which is predicted to grow at a significant rate during the forecast period.
Some prominent key players in the market are Acelity L.P. Inc., Smith & Nephew, B. Braun Melsungen AG, Coloplast A/S, ConvaTec Group, Paul Hartmann, Mölnlycke Health Care, Lohmann & Rauscher, Medline Industries and Integra Lifesciences.
By Wound Type
By End User
The wound debridement market is expected to increase at a CAGR of 6.1% from 2023 to 2032.
The wound debridement market size was estimated to be US$ 5 billion in 2021.
North America and Asia Pacific will rule the market in the forecast period.
The market is expanding due to an older population, increasing burn injury rates, and other skin illnesses.
Rising instrument prices and unawareness about using this equipment are restraining the market.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved